Introduction

This topic is closed.

Maphuti

Junior Member

Join Date: Jul 2022

Posts: 1
- Share
- Tweet
#1

Introduction

07-11-2022, 05:01 AM

Hi everyone,

I am Maphuti Ledwaba, from the South African National Biodiversity Institute. I am new on the forum and would like to learn more from you, specifically on analyzing Ion torrent data
Tags: None
mariaporter

Junior Member

Join Date: Apr 2022

Posts: 1
- Share
- Tweet
#2

07-29-2022, 11:01 AM

Hello Everyone, This is Maria Porter and I am a mental health consultant in Pennsylvania.
Comment
hundal

Junior Member

Join Date: Sep 2022

Posts: 1
- Share
- Tweet
#3

09-21-2022, 10:05 PM

Hello Everyone,This is Hundal Marck, Mental Health assistant in United States Of America.
Comment
ARTUROAP

Junior Member

Join Date: Mar 2023

Posts: 1
- Share
- Tweet
#4

03-04-2023, 06:57 PM

Hello everyone, I belong to a Peruvian hospital and I am interested in everything that concerns NGS with the Illumina platform.
Comment

Previous template Next

Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications

by SEQadmin2

Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

The systematic characterization of the human proteome has...
- Channel: Articles
07-20-2026, 11:48 AM
Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems

by SEQadmin2

Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
...
- Channel: Articles
07-09-2026, 11:10 AM
Cancer Drug Resistance: The Lingering Barrier to Rising Survival

by SEQadmin2

Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
- Channel: Articles
07-08-2026, 05:17 AM

Topics	Statistics	Last Post
Study Captures the First Moments of DNA Replication by SEQadmin2 Started by SEQadmin2, 07-24-2026, 12:17 PM	0 responses 25 views 0 reactions	Last Post by SEQadmin2 07-24-2026, 12:17 PM
Chemotherapy Leaves Detectable DNA Signatures in Childhood Tumors by SEQadmin2 Started by SEQadmin2, 07-23-2026, 11:41 AM	0 responses 20 views 0 reactions	Last Post by SEQadmin2 07-23-2026, 11:41 AM
Single-Cell Atlases Skew Toward European Ancestry, Analysis Finds by SEQadmin2 Started by SEQadmin2, 07-20-2026, 11:10 AM	0 responses 28 views 0 reactions	Last Post by SEQadmin2 07-20-2026, 11:10 AM
UC San Diego Bioengineers Map Gene Function in Human Stem Cells by SEQadmin2 Started by SEQadmin2, 07-13-2026, 10:26 AM	0 responses 38 views 0 reactions	Last Post by SEQadmin2 07-13-2026, 10:26 AM

Unconfigured Ad

Comment

Comment

Comment

Latest Articles

ad_right_rmr

News